Gyre Therapeutics (GYRE) Cost of Revenue (2020 - 2026)
Gyre Therapeutics (GYRE) reported Cost of Revenue of $2.21 million for Q2 2026, up 91.9% from $1.15 million a year earlier and up 80.0% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Cost of Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gyre Therapeutics' Cost of Revenue came in at $6.81 million, up 62.8% year-over-year; for FY2025, it was $5.42 million, up 39.4% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $3.88 million in FY2024 (-16.2%), $4.64 million in FY2023 (-3.3%), $4.79 million in FY2022 (-35.1%) and $7.38 million in FY2021 (-19.5%).
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue since Q4 2022.
- Year over year, Cost of Revenue has now increased in each of the last five quarters, with growth averaging 32.9% over the last eight quarters.
- The high point for year-over-year Cost of Revenue in five years was Q3 2021 (growth of 153.2%); the low point was Q4 2023 (a decline of 68.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.23 million (Q1 2026), $1.74 million (Q4 2025) and $1.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn | 2.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 894,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 958,000.00 |
| Jun 30, 2024 | 770,000.00 |
| Mar 31, 2024 | 979,000.00 |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Mar 31, 2022 | 798,000.00 |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | 2.31 Mn |
| Jun 30, 2021 | 1.14 Mn |
| Mar 31, 2021 | 1.48 Mn |
API Access
Gyre Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();